Dopaminergic Therapy for Anhedonia - 2
Dopaminergic Therapy for Anhedonia - 2
Recruiting · NCT06075771 · Registry updated 2026-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dopaminergic Therapy for Anhedonia - 2 | Anhedonia, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, depressive disorder, nervous system disorder | Recruiting | Phase 4 | 2026-01-28 | NCT06075771 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Emory University | 393 |
| National Institute of Mental Health (NIMH) | 702 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory University Hospital | Atlanta | United States | 131 |